Investing News NetworkYour trusted source for investing success

aptevo therapeutics

Top NASDAQ Biotech Stocks of 2020

Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436

Aptevo Therapeutics Reports First Quarter 2018 Financial Results

New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 Presented by Aptevo Therapeutics and Alligator Bioscience at Prominent Industry Conferences

Aptevo Therapeutics’ Bispecific Antibody APVO436 Shows Robust T-Cell Activation With Minimal Cytokine Release

Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update

Aptevo Therapeutics and Alligator Bioscience Prepare for IND Development

Aptevo Therapeutics Presents Key Features of ADAPTIR

Aptevo Shows New Clinical Data For IXINITY

Aptevo To Present New Data at Cancer Meeting

Blackstone Secures $22.6m for Mankayan Copper-Gold Drilling

C29 Metals shifts focus to Mayfield Copper Project

Equity Metals: Advancing High-grade, District-scale Silver and Gold Assets in British Columbia

South Harz Potash: A Globally Significant European Potash and Critical Minerals Opportunity

Ian Rodger Appointed Managing Director

South Harz Potash Limited

Equity Metals

Terra Clean Energy

BP

NevGold

FinEx Metals

MARKETS

COMMODITIES

CURRENCIES